Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled trial of tadalafil in Duchenne muscular dystrophy
KCT0000977Phase 3Recruiting
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tadalafil in Duchenne muscular dystrophy (DMD), sponsored by Eli Lilly and Company. Started Dec 2013; status: recruiting.
02
Drugs
tadalafil
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on KCT0000977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000977.